Research
RSDSA is Committed to Funding and Advocating for CRPS Research and to Supporting the Medical Community
Less than one percent of all dollars spent on health research are invested in pain research. It is up to us to ensure that the treatments of today are not those of tomorrow. Every donated dollar invested in CRPS research will help fund studies for better treatment and a cure.
Presently we are funding these ongoing CRPS research projects:
- Pain – a role for cross-talk between skin fibroblasts and the nociceptive system in skin of patients with Complex Regional Pain Syndrome (CRPS) ($235,880) submitted by PD Dr. Astrid Jüngel and Prof. Dr. med. et Dr. phil. Florian Brunner, Balgrist University Hospital and University Hospital Zurich
- Begun the analysis of RSDSA’s 10-study of how CRPS impacts the long-term health of people with CRPS
RSDSA has committed all of its available research funds to present and future research initiatives and is not accepting new applications.
Current Active CRPS Clinical Trials
To locate clinical trials focused on CRPS, visit clinicaltrials.gov and search for “CRPS”
- Ambros Therapeutics: Complex Regional Pain Syndrome-Relief and Improvement Study for Efficacy
- Stanford University: Transcranial Magnetic Stimulation for Complex Regional Pain Syndrome
- Stanford University: Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome
- UC San Diego: The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome
- Watch the replay of the May 2025 livestream with the lead researchers of the UC San Diego study
- Oregon State University: Childhood Experiences of People with EDS, CRPS, and/or POTS
- RSDSA has ended its 20-year study of the long-term health impact of CRPS on individuals diagnosed with it. We thank everyone who participated. We have begun the analysis of the data and hope to publish the results as soon as possible.
Please bookmark this page and return for updates, or subscribe to our newsletter to receive the latest information automatically. To help us continue our research funding efforts we encourage you to contribute.
